Menu

Dicerna Pharmaceuticals, Inc. DRNA

Full chart Compare
Set alert

Price alert · DRNA

All alert types
38.22 0.00 (+0.00%)

Apr 24, 2025, 3:47 PM EDT

38.21 Day range 38.24

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $461.00KExpenses → Selling, General & Admin: $72.13MExpenses → Research & Development: $205.38MGross Profit → Expenses: $164.31MRevenue → Gross Profit: $164.31MNet Loss → Expenses: $112.75MOther Income$461.00KGross Profit$164.31MNet Loss$112.75MExpenses$277.51MSelling, General & Admin$72.13MResearch & Development$205.38MRevenue$164.31M

Latest period ending Dec 31, 2020 · select a line to chart its full history

DRNA annual income statement
Fiscal yearFY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017FY 2016 Dec 31, 2016
164.31M23.90M6.18M1.03M0
164.31M23.90M6.18M1.03M0
-113.21M-128.19M-90.35M-60.74M-59.75M
-112.75M-120.46M-88.85M-60.20M-59.51M
-1.52-1.76-1.60-3.66-2.87
DRNA annual balance sheet
Fiscal yearFY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017FY 2016 Dec 31, 2016
126.77M152.82M54.24M68.79M20.86M
707.85M597.41M409.04M121.00M51.25M
570.09M445.21M208.35M19.92M10.04M
52.18M23.50M000
137.75M152.19M200.69M101.09M41.21M
DRNA annual cash flow
Fiscal yearFY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017FY 2016 Dec 31, 2016
175.11M-692.00K18.30M-45.33M-48.75M
-258.86M49.53M-202.73M-19.85M13.02M
59.42M52.89M169.88M112.73M534.00K
-11.75M-6.35M-359.00K-133.00K-449.00K
-24.32M101.73M-14.55M47.55M-35.19M